Liposomal Irinotecan Based FOLFIRI With Bevacizumab in First-line Treatment of Advanced Colorectal Cancer
Clinical trial NCT05969899 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05969899
- Sponsor
- Fudan University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-10
- Primary completion
- 2025-07-10
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.